Kadmon Holdings Inc. said late Tuesday it sold 6.25 million shares on its initial public offering at $12 a piece. In a statement, the drug developer said its stock is expected to begin trading Wednesday on the New York Stock Exchange under the symbol KDMN. Kadmon’s founder and former CEO, Sam Waksal, founded biopharmaceutical company ImClone Systems, the company at the center of an insider trading scandal that ensnared media personality Martha Stewart.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News